ONESOURCE
Invest with MTF
Invest Now
Invest in OneSource Specialty Pharma with 3.11X leverage
Performance
- Low
- ₹1,737
- High
- ₹1,824
- 52 Week Low
- ₹1,210
- 52 Week High
- ₹2,248
- Open Price₹1,773
- Previous Close₹1,773
- Volume204,449
Investment Returns
- Over 1 Month + 18.17%
- Over 3 Month + 0.68%
- Over 6 Month -17.47%
- Over 1 Year + 8.42%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 519.3
- PEG Ratio
- 4.4
- Market Cap Cr
- 20,747
- P/B Ratio
- 3.5
- Average True Range
- 63.46
- EPS
- 12.04
- Dividend Yield
- 0
- MACD Signal
- -4.96
- RSI
- 61.86
- MFI
- 78.16
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
Current Price
₹1,810.60
+
37.2
(2.1%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹1,697.18
- 50 Day
- ₹1,719.41
- 100 Day
- ₹1,751.50
- 200 Day
- ₹1,733.06
Resistance and Support
1763.47
- R3 1,859.93
- R2 1,824.47
- R1 1,798.93
- S1 1,737.93
- S2 1,702.47
- S3 1,676.93
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results | |
| 2025-05-05 | Audited Results | |
| 2025-01-29 | Quarterly Results |
OneSource Specialty Pharma F&O
About OneSource Specialty Pharma
- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Managing Director & CEO
- Mr. Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,810 As on 31 December, 2025 | 17:57
The Market Cap of OneSource Specialty Pharma is ₹20746.8 Cr As on 31 December, 2025 | 17:57
The P/E ratio of OneSource Specialty Pharma is 519.3 As on 31 December, 2025 | 17:57
The PB ratio of OneSource Specialty Pharma is 3.5 As on 31 December, 2025 | 17:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.